Folinic Acid, Fluorouracil, and Oxaliplatin Therapy for Recurrent Esophageal Cancer with Syndrome of Inadequate Antidiuretic Hormone Secretion (SIADH) After Preoperative Cisplatin/5-Fluorouracil Therapy

Ryoko Futai; Tomoo Yoshie; Tsuyoshi Sanuki; Yuta Inoue; Tetsuyuki Abe; Ayaka Sasaki; Takao Iemoto; Hiroki Hayashi; Takayuki Ose; Teruhisa Morikawa

doi:10.12659/AJCR.935121

15 February 2022 : Case report Japan

Folinic Acid, Fluorouracil, and Oxaliplatin Therapy for Recurrent Esophageal Cancer with Syndrome of Inadequate Antidiuretic Hormone Secretion (SIADH) After Preoperative Cisplatin/5-Fluorouracil Therapy

Unusual or unexpected effect of treatment, Rare disease

Ryoko Futai^1A*, Tomoo Yoshie^1B, Tsuyoshi Sanuki^1B, Yuta Inoue^1B, Tetsuyuki Abe^1B, Ayaka Sasaki^1B, Takao Iemoto^1B, Hiroki Hayashi^1B, Takayuki Ose^1B, Teruhisa Morikawa^1B

DOI: 10.12659/AJCR.935121

Am J Case Rep 2022; 23:e935121

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 1. (A) Thoracic and abdominal contrast-enhanced computed tomography (CT) before neoadjuvant chemotherapy (NAC). Tumor is indicated by arrows. (B) Fluorine-18-deoxyglucose (FDG) accumulation was 22.33 times the standard uptake value on positron emission tomography (PET)-CT before NAC. Tumor is indicated by arrows. (C) Thoracic and abdominal contrast-enhanced CT after NAC showing a marked reduction in the size of the esophageal lesion. Tumor accumulation is indicated by arrows. (D) FDG accumulation decreased to 18.69 on PET-CT after NAC. Tumor accumulation is indicated by arrows.

Back to the Article

Folinic Acid, Fluorouracil, and Oxaliplatin Therapy for Recurrent Esophageal Cancer with Syndrome of Inadequate Antidiuretic Hormone Secretion (SIADH) After Preoperative Cisplatin/5-Fluorouracil Therapy

Your Privacy